Stocks and Investing Stocks and Investing
Wed, August 25, 2021
Tue, August 24, 2021

Joseph Stringer Maintained (TBPH) at Strong Buy with Decreased Target to $18 on, Aug 24th, 2021


Published on 2024-10-27 17:44:46 - WOPRAI, Joseph Stringer
  Print publication without navigation


Joseph Stringer of Needham, Maintained "Theravance Biopharma, Inc." (TBPH) at Strong Buy with Decreased Target from $32 to $18 on, Aug 24th, 2021.

Joseph has made no other calls on TBPH in the last 4 months.



There is 1 other peer that has a rating on TBPH. Out of the 1 peers that are also analyzing TBPH, 0 agree with Joseph's Rating of Hold.



This is the rating of the analyst that currently disagrees with Joseph


  • Vikram Purohit of "Morgan Stanley" Maintained at Buy with Decreased Target to $27 on, Friday, July 16th, 2021
Contributing Sources